Delivering a Cost Effective, Practical and Robust Cell Therapy Supply Chain

FDA approvals for  Novartis’ Kymriah™ and Kite’s Yescarta™ in 2017 ushered in a new era of medical treatments using cell and gene therapies.  Transporting these high value, unique, and often irreplaceable autologous cells from point of collection, to processing center, and back to the patient for administration calls for a paradigm change to the traditional…

Read More

Clinical methods of cryopreservation for donor lymphocyte infusions vary in their ability to preserve functional T-cell subpopulations

Worsham, D. N., Reems, J.-A., Szczepiorkowski, Z. M., McKenna, D. H., Leemhuis, T., Mathew, A. J., Cancelas, J. A. and Biomedical Excellence for Safer Transfusion (BEST) Collaborative Group. Clinical methods of cryopreservation for donor lymphocyte infusions vary in their ability to preserve functional T-cell subpopulations. Transfusion (Pre-Print) doi:10.1111/trf.14112.

Read More